company background image
1737 logo

Taiyen Biotech TWSE:1737 Stock Report

Last Price

NT$35.20

Market Cap

NT$6.8b

7D

4.5%

1Y

5.2%

Updated

18 Apr, 2024

Data

Company Financials

Taiyen Biotech Co., Ltd.

TWSE:1737 Stock Report

Market Cap: NT$6.8b

1737 Stock Overview

Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally.

1737 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends3/6

Taiyen Biotech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Taiyen Biotech
Historical stock prices
Current Share PriceNT$35.20
52 Week HighNT$40.50
52 Week LowNT$32.80
Beta0.20
1 Month Change3.99%
3 Month Change3.99%
1 Year Change5.23%
3 Year Change1.15%
5 Year Change10.69%
Change since IPO32.90%

Recent News & Updates

Recent updates

Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Apr 24
Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

Apr 09
Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Mar 25
A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Mar 12
Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Feb 14
Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Feb 01
Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Jan 17
Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

Jan 04
Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Dec 22
A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Dec 09
How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

Nov 24
Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

Shareholder Returns

1737TW FoodTW Market
7D4.5%-2.0%-2.6%
1Y5.2%3.5%25.9%

Return vs Industry: 1737 underperformed the TW Food industry which returned 2.6% over the past year.

Return vs Market: 1737 underperformed the TW Market which returned 24.4% over the past year.

Price Volatility

Is 1737's price volatile compared to industry and market?
1737 volatility
1737 Average Weekly Movement0.8%
Food Industry Average Movement2.1%
Market Average Movement4.5%
10% most volatile stocks in TW Market8.4%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 1737 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1737's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1952n/aShi-Hui Chenwww.tybio.com.tw

Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. Its products portfolio includes various salt and seawater chemical products; bath salt, bath salt milk, salt soap, algae soap, and shampoo; beverage and raw drinking water; skin care; toothpaste, salt mouthwash, and eye glass care solution; salt for washing fruits and vegetables; and food and food additives. The company also manufactures western medicine, environmental pharmaceuticals, and cosmetics.

Taiyen Biotech Co., Ltd. Fundamentals Summary

How do Taiyen Biotech's earnings and revenue compare to its market cap?
1737 fundamental statistics
Market capNT$6.76b
Earnings (TTM)NT$300.39m
Revenue (TTM)NT$3.41b

23.4x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1737 income statement (TTM)
RevenueNT$3.41b
Cost of RevenueNT$2.15b
Gross ProfitNT$1.26b
Other ExpensesNT$957.09m
EarningsNT$300.39m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.50
Gross Margin36.89%
Net Profit Margin8.81%
Debt/Equity Ratio2.9%

How did 1737 perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

80%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.